A new London-based centre will pioneer research to optimise how antimicrobial drugs are used to both improve patient care and preserve antibiotics.
As part of a drive to tackle antibiotic-resistant infections, the Department of Health and Social Care (DHSC) is providing funding to several UK institutions, including £4 million for the new Centre for Antimicrobial Optimisation (CAMO) at Imperial College London to improve the use of antimicrobials so that treatments can be tailored for the individual, organism, and infection to improve patient care and reduce antimicrobial resistance (AMR).
Led by Prof Alison Holmes from the Department of Medicine, Imperial College London, the CAMO will support and deliver innovative technologies to optimise the use of antibiotics, antifungals, and antivirals. The new centre brings together a range of expertise from across the College and partnerships with the NHS, to support and deliver research to improve infection management.
Prof Holmes said, “Antimicrobial resistance is a growing global issue and threatens current medical and surgical practice. The development of novel antimicrobials is extremely limited, and we must therefore conserve our existing drugs through innovative approaches and technological advances.”
Some of the cutting-edge technologies being developed at CAMO will be showcased at the Technical Solutions to Support Infection Management and Address AMR summit, taking place at Imperial College London on 9 July 2019.
Outgoing Chief Medical Officer Prof Dame Sally Davies, who has been appointed UK special envoy on AMR, will chair an interactive panel discussion at next week’s summit on how academia, government, funding bodies, and industry partners can work together to address this national and global challenge.